In 2010, Mary Boswell was only given six months to two years to live. Today, she's training to participate in a 5K walk.

Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the ...

Researchers at Trinity Translational Medicine Institute (TTMI) and the Irish Mycobacterial Reference Laboratory at St James's ...

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

At Dell Children's team of specialists work together for better outcomes for its littlest babies with bronchopulmonary ...

By cracking a medical mystery, Northwestern Medicine researchers may be on the cusp of discovering new drugs to treat the ...

Iams, MD, MSCI, examined outcomes of the phase 3 IMforte trial in extensive-stage small cell lung cancer. Adding immunotherapy to platinum-based chemotherapy is an established standard of care for ...

Results of a recent study show adults with cardiovascular disease (CVD) have an increased risk of contracting shingles.

Bent bone dysplasia (BBD) is a perinatal-lethal skeletal disorder caused by pathogenic FGFR2 mutations that disrupt bone ...

Historically, RSV has been associated with infants, but they are not the only group that can be affected by serious RSV ...

Between 2024 and 2025, Jacksonville's air quality conditions declined from "A" to "B" in the American Lung Association’s ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.